Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Yuya, Koda"'
Autor:
Saki Kawase, Masatoshi Sakurai, Kyoko Masuda, Yusuke Kubota, Takahide Shindo, Ami Inokuchi, Hiroyoshi Hayashi, Misa Nakayasu, Yuka Shiozawa, Tomohiro Hirai, Takahiro Inoue, Takayuki Fujii, Haryoon Kim, Yuya Koda, Jun Kato, Keisuke Kataoka
Publikováno v:
Journal of Clinical & Experimental Hematopathology; 2024, Vol. 64 Issue 3, p261-267, 7p
Autor:
Shinya Fujita, Hidenori Kasahara, Jun Kato, Yuya Koda, Kohei Shiroshita, Kentaro Yamaguchi, Mikio Okayama, Ryohei Abe, Taku Kikuchi, Takayuki Shimizu, Takehiko Mori, Keisuke Kataoka, Shinichiro Okamoto
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 11, p1549-1562, 14p
Autor:
Ho Namkoong, Makoto Ishii, Takehiko Mori, Hiroaki Sugiura, Sadatomo Tasaka, Masatoshi Sakurai, Yuya Koda, Jun Kato, Naoki Hasegawa, Shinichiro Okamoto, Tomoko Betsuyaku
Publikováno v:
BMC Pulmonary Medicine, Vol 17, Iss 1, Pp 1-9 (2017)
Abstract Background Late-onset noninfectious pulmonary complications (LONIPCs), which occur more than 3 months after allogeneic hematopoietic stem cell transplantation (HSCT), are major causes of morbidity and mortality after transplantation. Among L
Externí odkaz:
https://doaj.org/article/de133e1bc3aa40bcb9b22140b2a104b1
Autor:
Yuho Najima, Takayoshi Tachibana, Yusuke Takeda, Yuya Koda, Yasuhisa Aoyama, Takashi Toya, Aiko Igarashi, Masatsugu Tanaka, Emiko Sakaida, Ryohei Abe, Makoto Onizuka, Takeshi Kobayashi, Noriko Doki, Kazuteru Ohashi, Heiwa Kanamori, Takuma Ishizaki, Akira Yokota, Satoshi Morita, Shinichiro Okamoto, Yoshinobu Kanda
Publikováno v:
Annals of Hematology. 101:2719-2729
This 3+3 dose-escalation phase I multicenter study investigated the optimal dose of azacitidine (AZA) for post-hematopoietic stem cell transplantation (HSCT) maintenance, which remains unknown in Japan. Recipients of a first HSCT for high-risk myelod
Autor:
Daiki Iguchi, Yuya Koda
Publikováno v:
Pacific Journal of Mathematics. 315:347-368
We prove that if the distance of a bridge decomposition of a link with respect to a Heegaard splitting of a $3$-manifold is at least $6$, then the Goeritz group is a finite group.
Comment: 23 pages, 17 figures; minor changes
Comment: 23 pages, 17 figures; minor changes
Autor:
Shinya Fujita, Masatoshi Sakurai, Hidenori Kasahara, Jun Kato, Yuya Koda, Kentaro Yamaguchi, Kohei Shiroshita, Mikio Okayama, Ryohei Abe, Taku Kikuchi, Takayuki Shimizu, Takehiko Mori, Keisuke Kataoka, Shinichiro Okamoto
Second- and third-generation (2/3G) tyrosine kinase inhibitors (TKIs) possess excellent treatment effects on chronic myeloid leukemia (CML), and at least one 2/3G TKI is mostly incorporated into the first treatment of CML in all phases. However, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d7f3963727f09ecbe84d03b40fc7f25
https://doi.org/10.21203/rs.3.rs-2050971/v1
https://doi.org/10.21203/rs.3.rs-2050971/v1
Autor:
Kota Mizuno, Masatoshi Sakurai, Jun Kato, Kentaro Yamaguchi, Ryohei Abe, Yuya Koda, Keisuke Kataoka, Takehiko Mori
Publikováno v:
Transplant Infectious Disease. 24
Letermovir has been approved as a novel cytomegalovirus (CMV) prophylactic agent after allogeneic hematopoietic stem cell transplantation (HSCT). However, there are still insufficient data to properly evaluate the real-world role of letermovir, and t
Autor:
Rie Yamazaki, Yohei Tomita, Taku Kikuchi, Miki Koh, Masuho Saburi, Sumiko Kohashi, Yoko Ozawa, Jun Kato, Masatoshi Sakurai, Yuya Koda, Ryohei Abe, Takehiko Mori
Publikováno v:
Bone Marrow Transplantation. 56:1266-1271
Although cytomegalovirus (CMV) remains a leading cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT), the incidence of CMV retinitis is considered to be lower than the incidence of CMV infection in other o
Publikováno v:
Journal of Topology and Analysis. 14:945-968
Any knot $K$ in genus-$1$ $1$-bridge position can be moved by isotopy to lie in a union of $n$ parallel tori tubed by $n-1$ tubes so that $K$ intersects each tube in two spanning arcs, which we call a leveling of the position. The minimal $n$ for whi
Autor:
Shinichiro Okamoto, Hiroki Yokoyama, Masahiro Onoda, Taku Kikuchi, Chikako Ohwada, Yuhei Nagao, Makoto Onizuka, Kunihiko Morita, Emiko Sakaida, Katsuhiro Shono, Jun Kato, Yutaro Hino, Kana Matsumoto, Tatsuzo Mishina, Yuya Koda, Hiroaki Shimizu, Akira Yokota, Yusuke Takeda, Takehiko Mori
Publikováno v:
International Journal of Hematology. 113:128-133
Busulfan (Bu) has been used in combination with fludarabine (Flu; BuFlu) or cyclophosphamide (Cy; BuCy) as conditioning for allogeneic hematopoietic stem cell transplantation (HSCT). This multi-institutional prospective study compared pharmacokinetic